Population Health Colorectal Cancer Screening Program

Eradicating Colorectal Cancer by Improving Screening and Reducing Disparities

The Population Health Colorectal Cancer Screening Program is a collaborative effort between Fred Hutch and UW Medicine. Our goals are to eradicate colorectal cancer by improving screening, reducing racial, ethnic, and socioeconomic disparities, and improving follow-up for those with abnormal non-invasive screening tests. We do this through quality improvement, research, community engagement, and informing local and national health policy.

Key Priorities

Man and medical provider speaking

Improving Access for Screening

Two women walking and talking

Tailored Interventions

Dr. Rachel Issaka speaking with visitors at community event

Community Education and Awareness

Improving Access for Screening

By using mailed stool-based colorectal cancer screening tests (fecal immunochemical test - FIT), our team is improving access to colorectal cancer prevention.

Read our inaugural annual report (September 2021 - June 2022)

Population Health Colorectal Cancer Screening Program team photo

Our Team

Learn more about the Population Health CRC Screening program team.

People speaking and taking notes around a table

Health Equity Working Group

The Health Equity Working Group meets quarterly to advise the Population Health CRC Screening Program. Learn more about the working group.

Early Detection and Prevention Research

Our research focuses on the early detection and prevention of colorectal cancer through increased screening, especially among medically underserved populations. Our current projects include evaluations of novel interventions to increase adherence to colorectal cancer screening and follow-up of abnormal results. 

Recent News

More News

Dr. Rachel Issaka receives the Kathryn Surace-Smith Endowed Chair in Health Equity Research
Flexible funding will further physician-scientist’s work in colorectal cancer and health inequities
Fred Hutch News Service | Feb. 2, 2022

The COVID cancer effect
Oncologists are grappling with predicting—and mitigating—the effects of the pandemic
Scientific American | Dec. 1, 2021

Which colon cancer screening is best?
Colon cancer screening can save lives. There are several types of screening options, but any screening is better than none.
U.S. News & World Report | Aug. 27, 2021

Study ID’s major roadblocks to follow-up colon-cancer care
Lack of both transportation and interpreters can stall a clinic visit after an at-home test raises a red flag.
UW PostScript Blog | Aug. 10, 2021

Dr. Rachel Issaka, Program Director

“Screening is a way to not only prevent disease but reduce racial and economic disparities. We need to close that gap so that every citizen can benefit from the advances in cancer care and prevention.”

Dr. Rachel Issaka, Program Director

Contact Us 

Amanda Kimura

Amanda Kimura, MPH

Last Modified, October 05, 2022